Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00931996 · ClinicalTrials.gov registry record · NA
Oculomotor and Spatial Cognition Deficits in Schizophrenia
A NA study, sponsored by University of Illinois at Chicago.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT00931996 is a NA study that was terminated before completion, run by University of Illinois at Chicago. The registered enrollment target is 12 participants.
The verdict
NCT00931996, a NA study, was terminated before completion, sponsored by University of Illinois at Chicago.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
DESCRIPTION: (Verbatim from the Applicant's Abstract) Abnormalities of eye movement control and spatial cognition are well-established deficits in schizophrenia. However, the regional disturbances in brain function causing these deficits are not yet known. This application proposes a series of integrated behavioral studies designed to identify causes of deficits in schizophrenia.
Interventions
- DRUG Antipsychotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00931996
The ClinicalTrials.gov registry entry for NCT00931996 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Antipsychotic is the first listed.
NCT00931996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00931996 about?
NCT00931996 is a clinical study titled "Oculomotor and Spatial Cognition Deficits in Schizophrenia". DESCRIPTION: (Verbatim from the Applicant's Abstract) Abnormalities of eye movement control and spatial cognition are well-established deficits in schizophrenia. However, the regional disturbances in brain function causing these deficits are not yet known. This application proposes a series of integ...
What is the current status of trial NCT00931996?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2009-06. Estimated completion is 2011-11.
What interventions are being tested in trial NCT00931996?
The interventions under investigation include: Antipsychotic (DRUG).
Who is sponsoring clinical trial NCT00931996?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.